EVMN

Evommune, Inc.

Insider trading activity for Evommune, Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

+$146.3K

net buying

Bought(2 · 2 insiders): $146.3K
Sold(0 · 0 insiders): $0

Past 6 months

-$2.1M

net selling

Bought(2 · 2 insiders): $146.3K
Sold(9 · 6 insiders): $2.3M

Past 12 months

+$67.9M

net buying

Bought(7 · 6 insiders): $70.2M
Sold(9 · 6 insiders): $2.3M

Transaction history

The 100 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Jul 8	Carver Kyle	Chief Financial Officer	PBUY★	1,000	$13.26	$13.3K	+1.7%	Open the original filing on SEC.gov
Jul 7	Kirsch Arthur S	Director	PBUY★	10,000	$13.30	$133K	—	Open the original filing on SEC.gov
Jun 22	Patel Jeegar Pravinkumar	Chief Scientific Officer	MEXER◷◆	1,488	—	—	—	Open the original filing on SEC.gov
Jun 22	Patel Jeegar Pravinkumar	Chief Scientific Officer	SSELL◷	1,488	$22.50	$33.5K	-3.1%	Open the original filing on SEC.gov
Jun 22	Patel Jeegar Pravinkumar	Chief Scientific Officer	MEXER◷	1,488	$3.84	$5.7K	+3.2%	Open the original filing on SEC.gov
Jun 22	Pena Luis C.	President & CEO	SSELL◷	7,438	$22.71	$168.9K	-1.2%	Open the original filing on SEC.gov
Jun 22	Drew Janice Suzann	Chief of Dev. Operations	MEXER◷◆	16,161	—	—	—	Open the original filing on SEC.gov
Jun 22	Drew Janice Suzann	Chief of Dev. Operations	MEXER◷◆	3,839	—	—	—	Open the original filing on SEC.gov
Jun 22	Drew Janice Suzann	Chief of Dev. Operations	SSELL◷	20,000	$22.63	$452.6K	-22.8%	Open the original filing on SEC.gov
Jun 22	Drew Janice Suzann	Chief of Dev. Operations	MEXER◷	16,161	$2.99	$48.3K	+22.6%	Open the original filing on SEC.gov
Jun 22	Drew Janice Suzann	Chief of Dev. Operations	MEXER◷	3,839	$3.84	$14.7K	+5.7%	Open the original filing on SEC.gov
Jun 2	Kirsch Arthur S	Director	AGRANT◆	15,673	—	—	—	Open the original filing on SEC.gov
Jun 2	McGraw Benjamin F III	Director	AGRANT◆	15,673	—	—	—	Open the original filing on SEC.gov
Jun 2	Cohen David E	Director	AGRANT◷◆	15,673	—	—	—	Open the original filing on SEC.gov
Jun 2	Cohen David E	Director	SSELL◷	600	$21.38	$12.8K	-3.3%	Open the original filing on SEC.gov
Jun 2	Cohen David E	Director	SSELL◷	5,456	$20.21	$110.3K	-23.1%	Open the original filing on SEC.gov
Jun 1	Patel Jeegar Pravinkumar	Chief Scientific Officer	MEXER◷◆	13,512	—	—	—	Open the original filing on SEC.gov
Jun 1	Patel Jeegar Pravinkumar	Chief Scientific Officer	SSELL◷	16,687	$22.74	$379.5K	-26.5%	Open the original filing on SEC.gov
Jun 1	Patel Jeegar Pravinkumar	Chief Scientific Officer	MEXER◷	13,512	$3.84	$51.9K	+27.3%	Open the original filing on SEC.gov
Jun 1	Pena Luis C.	President & CEO	SSELL◷	16,787	$22.74	$381.7K	-2.6%	Open the original filing on SEC.gov
May 28	Moss Gregory S.	Chief Business & Legal…	MEXER◷◆	14,223	—	—	—	Open the original filing on SEC.gov
May 28	Moss Gregory S.	Chief Business & Legal…	SSELL◷	14,223	$22.83	$324.7K	-18.9%	Open the original filing on SEC.gov
May 28	Moss Gregory S.	Chief Business & Legal…	MEXER◷	14,223	$1.71	$24.3K	+23.4%	Open the original filing on SEC.gov
May 28	Carver Kyle	Chief Financial Officer	MEXER◷◆	15,000	—	—	—	Open the original filing on SEC.gov
May 28	Carver Kyle	Chief Financial Officer	SSELL◷	18,175	$22.84	$415.1K	-23.4%	Open the original filing on SEC.gov
May 28	Carver Kyle	Chief Financial Officer	MEXER◷	15,000	$2.99	$44.9K	+24.0%	Open the original filing on SEC.gov
Apr 16	Patel Jeegar Pravinkumar	Chief Scientific Officer	AGRANT◆	69,315	—	—	—	Open the original filing on SEC.gov
Apr 16	Moss Gregory S.	Chief Business & Legal…	AGRANT◆	115,279	—	—	—	Open the original filing on SEC.gov
Apr 16	Pena Luis C.	President & CEO	AGRANT◆	291,420	—	—	—	Open the original filing on SEC.gov
Apr 16	Drew Janice Suzann	Chief of Dev. Operations	AGRANT◆	73,892	—	—	—	Open the original filing on SEC.gov
Apr 16	Carver Kyle	Chief Financial Officer	AGRANT◆	98,946	—	—	—	Open the original filing on SEC.gov
Apr 16	Bauer Eugene	Chief Medical Officer	AGRANT◆	51,117	—	—	—	Open the original filing on SEC.gov
Feb 17	Ra Capital Management,…	Director	AGRANT	35,868	$27.88	$1M	+1.3%	Open the original filing on SEC.gov
Feb 17	Verduyn-van Weegen…	Director, 10% Owner	AGRANT	358,680	$27.88	$10M	+7.3%	Open the original filing on SEC.gov
Feb 17	LSP 7 Cooperative UA	Director, 10% Owner	AGRANT	358,680	$27.88	$10M	+7.3%	Open the original filing on SEC.gov
Dec 19, 2025	Hopfner Robert Lorne	Director, 10% Owner	PBUY	1,000	$17.35	$17.4K	+33.1%	Open the original filing on SEC.gov
Dec 9, 2025	Patel Jeegar Pravinkumar	Chief Scientific Officer	FTAX	7,513	$17.84	$134K	-13.2%	Open the original filing on SEC.gov
Dec 9, 2025	Moss Gregory S.	Chief Business & Legal…	FTAX	13,624	$17.84	$243.1K	-18.3%	Open the original filing on SEC.gov
Dec 9, 2025	Pena Luis C.	President & CEO	FTAX	28,138	$17.84	$502K	-4.1%	Open the original filing on SEC.gov
Dec 9, 2025	Drew Janice Suzann	EVP, Operations	FTAX	5,074	$17.84	$90.5K	-7.0%	Open the original filing on SEC.gov
Dec 9, 2025	Carver Kyle	Chief Financial Officer	FTAX	13,290	$17.84	$237.1K	-17.5%	Open the original filing on SEC.gov
Dec 9, 2025	Bauer Eugene	Chief Medical Officer	FTAX	1,478	$17.84	$26.4K	-0.5%	Open the original filing on SEC.gov
Dec 8, 2025	Bauer Eugene	Chief Medical Officer	AGRANT◆	100,000	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Verduyn-van Weegen…	Director, 10% Owner	CCONV◆	6.6M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Verduyn-van Weegen…	Director, 10% Owner	CCONV◆	5.1M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Verduyn-van Weegen…	Director, 10% Owner	CCONV◆	15.5M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Verduyn-van Weegen…	Director, 10% Owner	PBUY	1.6M	$16.00	$25M	+46.4%	Open the original filing on SEC.gov
Nov 7, 2025	Verduyn-van Weegen…	Director, 10% Owner	CCONV	3.4M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Patel Jeegar Pravinkumar	Chief Scientific Officer	CCONV◆	25,000	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Patel Jeegar Pravinkumar	Chief Scientific Officer	CCONV	3,175	—	—	+5.9%	Open the original filing on SEC.gov
Nov 7, 2025	LSP 7 Cooperative UA	10% Owner	CCONV◆	6.6M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	LSP 7 Cooperative UA	10% Owner	CCONV◆	5.1M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	LSP 7 Cooperative UA	10% Owner	CCONV◆	15.5M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	LSP 7 Cooperative UA	10% Owner	PBUY	1.6M	$16.00	$25M	+46.4%	Open the original filing on SEC.gov
Nov 7, 2025	LSP 7 Cooperative UA	10% Owner	CCONV	3.4M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Moss Gregory S.	Chief Business & Legal…	CCONV◆	25,000	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Moss Gregory S.	Chief Business & Legal…	CCONV	3,175	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Pena Luis C.	President & CEO	CCONV◆	206,355	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Pena Luis C.	President & CEO	CCONV	24,225	—	—	+3.7%	Open the original filing on SEC.gov
Nov 7, 2025	Hopfner Robert Lorne	Director, 10% Owner	CCONV◆	2.5M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Hopfner Robert Lorne	Director, 10% Owner	CCONV◆	313,571	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Hopfner Robert Lorne	Director, 10% Owner	CCONV◆	313,571	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Hopfner Robert Lorne	Director, 10% Owner	CCONV◆	2.1M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Hopfner Robert Lorne	Director, 10% Owner	CCONV◆	1.9M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Hopfner Robert Lorne	Director, 10% Owner	CCONV◆	7.2M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Hopfner Robert Lorne	Director, 10% Owner	CCONV◆	2.6M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Hopfner Robert Lorne	Director, 10% Owner	CCONV◆	3.6M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Hopfner Robert Lorne	Director, 10% Owner	CCONV◆	7.1M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Hopfner Robert Lorne	Director, 10% Owner	CCONV◆	25,790	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Hopfner Robert Lorne	Director, 10% Owner	CCONV	294,502	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Hopfner Robert Lorne	Director, 10% Owner	CCONV	1.6M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Hopfner Robert Lorne	Director, 10% Owner	CCONV	1.4M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Hopfner Robert Lorne	Director, 10% Owner	CCONV	3,026	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Ra Capital Management,…	Director, 10% Owner	CCONV◆	5.9M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Ra Capital Management,…	Director, 10% Owner	CCONV◆	12.9M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Ra Capital Management,…	Director, 10% Owner	PBUY	92,904	$16.00	$1.5M	+13.4%	Open the original filing on SEC.gov
Nov 7, 2025	Ra Capital Management,…	Director, 10% Owner	PBUY	1.2M	$16.00	$18.5M	+76.3%	Open the original filing on SEC.gov
Nov 7, 2025	Ra Capital Management,…	Director, 10% Owner	CCONV	691,441	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Ra Capital Management,…	Director, 10% Owner	CCONV	1.5M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Pivotal bioVenture…	Director, 10% Owner	CCONV◆	2.5M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Pivotal bioVenture…	Director, 10% Owner	CCONV◆	313,571	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Pivotal bioVenture…	Director, 10% Owner	CCONV◆	313,571	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Pivotal bioVenture…	Director, 10% Owner	CCONV◆	2.1M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Pivotal bioVenture…	Director, 10% Owner	CCONV◆	1.9M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Pivotal bioVenture…	Director, 10% Owner	CCONV◆	7.2M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Pivotal bioVenture…	Director, 10% Owner	CCONV◆	2.6M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Pivotal bioVenture…	Director, 10% Owner	CCONV◆	3.6M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Pivotal bioVenture…	Director, 10% Owner	CCONV◆	7.1M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Pivotal bioVenture…	Director, 10% Owner	CCONV	294,502	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Pivotal bioVenture…	Director, 10% Owner	CCONV	1.6M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Pivotal bioVenture…	Director, 10% Owner	CCONV	1.4M	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Drew Janice Suzann	EVP, Operations	CCONV◆	12,500	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Drew Janice Suzann	EVP, Operations	CCONV	1,587	—	—	+2.2%	Open the original filing on SEC.gov
Nov 7, 2025	Cohen David E	Director	CCONV◆	51,588	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Cohen David E	Director	CCONV	6,056	—	—	+34.4%	Open the original filing on SEC.gov
Nov 7, 2025	Carver Kyle	Chief Financial Officer	CCONV◆	25,000	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Carver Kyle	Chief Financial Officer	CCONV	3,175	—	—	+4.4%	Open the original filing on SEC.gov
Nov 7, 2025	Bauer Eugene	Chief Medical Officer	CCONV◆	12,500	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Bauer Eugene	Chief Medical Officer	CCONV◆	206,355	—	—	—	Open the original filing on SEC.gov
Nov 7, 2025	Bauer Eugene	Chief Medical Officer	CCONV	25,812	—	—	+10.5%	Open the original filing on SEC.gov

PBUY★$13.3K

Carver Kyle · Chief Financial…Jul 8

1,000 sh @ $13.26 · +1.7% own

PBUY★$133K

Kirsch Arthur S · DirectorJul 7

10,000 sh @ $13.30

MEXER◷◆—

Patel Jeegar Pravinkumar · Chief Scientific…Jun 22

1,488 sh

SSELL◷$33.5K

Patel Jeegar Pravinkumar · Chief Scientific…Jun 22

1,488 sh @ $22.50 · -3.1% own

MEXER◷$5.7K

Patel Jeegar Pravinkumar · Chief Scientific…Jun 22

1,488 sh @ $3.84 · +3.2% own

SSELL◷$168.9K

Pena Luis C. · President & CEOJun 22

7,438 sh @ $22.71 · -1.2% own

MEXER◷◆—

Drew Janice Suzann · Chief of Dev.…Jun 22

16,161 sh

MEXER◷◆—

Drew Janice Suzann · Chief of Dev.…Jun 22

3,839 sh

SSELL◷$452.6K

Drew Janice Suzann · Chief of Dev.…Jun 22

20,000 sh @ $22.63 · -22.8% own

MEXER◷$48.3K

Drew Janice Suzann · Chief of Dev.…Jun 22

16,161 sh @ $2.99 · +22.6% own

MEXER◷$14.7K

Drew Janice Suzann · Chief of Dev.…Jun 22

3,839 sh @ $3.84 · +5.7% own

AGRANT◆—

Kirsch Arthur S · DirectorJun 2

15,673 sh

AGRANT◆—

McGraw Benjamin F III · DirectorJun 2

15,673 sh

AGRANT◷◆—

Cohen David E · DirectorJun 2

15,673 sh

SSELL◷$12.8K

Cohen David E · DirectorJun 2

600 sh @ $21.38 · -3.3% own

SSELL◷$110.3K

Cohen David E · DirectorJun 2

5,456 sh @ $20.21 · -23.1% own

MEXER◷◆—

Patel Jeegar Pravinkumar · Chief Scientific…Jun 1

13,512 sh

SSELL◷$379.5K

Patel Jeegar Pravinkumar · Chief Scientific…Jun 1

16,687 sh @ $22.74 · -26.5% own

MEXER◷$51.9K

Patel Jeegar Pravinkumar · Chief Scientific…Jun 1

13,512 sh @ $3.84 · +27.3% own

SSELL◷$381.7K

Pena Luis C. · President & CEOJun 1

16,787 sh @ $22.74 · -2.6% own

MEXER◷◆—

Moss Gregory S. · Chief Business &…May 28

14,223 sh

SSELL◷$324.7K

Moss Gregory S. · Chief Business &…May 28

14,223 sh @ $22.83 · -18.9% own

MEXER◷$24.3K

Moss Gregory S. · Chief Business &…May 28

14,223 sh @ $1.71 · +23.4% own

MEXER◷◆—

Carver Kyle · Chief Financial…May 28

15,000 sh

SSELL◷$415.1K

Carver Kyle · Chief Financial…May 28

18,175 sh @ $22.84 · -23.4% own

MEXER◷$44.9K

Carver Kyle · Chief Financial…May 28

15,000 sh @ $2.99 · +24.0% own

AGRANT◆—

Patel Jeegar Pravinkumar · Chief Scientific…Apr 16

69,315 sh

AGRANT◆—

Moss Gregory S. · Chief Business &…Apr 16

115,279 sh

AGRANT◆—

Pena Luis C. · President & CEOApr 16

291,420 sh

AGRANT◆—

Drew Janice Suzann · Chief of Dev.…Apr 16

73,892 sh

AGRANT◆—

Carver Kyle · Chief Financial…Apr 16

98,946 sh

AGRANT◆—

Bauer Eugene · Chief Medical…Apr 16

51,117 sh

AGRANT$1M

Ra Capital Management,… · DirectorFeb 17

35,868 sh @ $27.88 · +1.3% own

AGRANT$10M

Verduyn-van Weegen… · Director, 10%…Feb 17

358,680 sh @ $27.88 · +7.3% own

AGRANT$10M

LSP 7 Cooperative UA · Director, 10%…Feb 17

358,680 sh @ $27.88 · +7.3% own

PBUY$17.4K

Hopfner Robert Lorne · Director, 10%…Dec 19, 2025

1,000 sh @ $17.35 · +33.1% own

FTAX$134K

Patel Jeegar Pravinkumar · Chief Scientific…Dec 9, 2025

7,513 sh @ $17.84 · -13.2% own

FTAX$243.1K

Moss Gregory S. · Chief Business &…Dec 9, 2025

13,624 sh @ $17.84 · -18.3% own

FTAX$502K

Pena Luis C. · President & CEODec 9, 2025

28,138 sh @ $17.84 · -4.1% own

FTAX$90.5K

Drew Janice Suzann · EVP, OperationsDec 9, 2025

5,074 sh @ $17.84 · -7.0% own

FTAX$237.1K

Carver Kyle · Chief Financial…Dec 9, 2025

13,290 sh @ $17.84 · -17.5% own

FTAX$26.4K

Bauer Eugene · Chief Medical…Dec 9, 2025

1,478 sh @ $17.84 · -0.5% own

AGRANT◆—

Bauer Eugene · Chief Medical…Dec 8, 2025

100,000 sh

CCONV◆—

Verduyn-van Weegen… · Director, 10%…Nov 7, 2025

6.6M sh

CCONV◆—

Verduyn-van Weegen… · Director, 10%…Nov 7, 2025

5.1M sh

CCONV◆—

Verduyn-van Weegen… · Director, 10%…Nov 7, 2025

15.5M sh

PBUY$25M

Verduyn-van Weegen… · Director, 10%…Nov 7, 2025

1.6M sh @ $16.00 · +46.4% own

CCONV—

Verduyn-van Weegen… · Director, 10%…Nov 7, 2025

3.4M sh

CCONV◆—

Patel Jeegar Pravinkumar · Chief Scientific…Nov 7, 2025

25,000 sh

CCONV—

Patel Jeegar Pravinkumar · Chief Scientific…Nov 7, 2025

3,175 sh · +5.9% own

CCONV◆—

LSP 7 Cooperative UA · 10% OwnerNov 7, 2025

6.6M sh

CCONV◆—

LSP 7 Cooperative UA · 10% OwnerNov 7, 2025

5.1M sh

CCONV◆—

LSP 7 Cooperative UA · 10% OwnerNov 7, 2025

15.5M sh

PBUY$25M

LSP 7 Cooperative UA · 10% OwnerNov 7, 2025

1.6M sh @ $16.00 · +46.4% own

CCONV—

LSP 7 Cooperative UA · 10% OwnerNov 7, 2025

3.4M sh

CCONV◆—

Moss Gregory S. · Chief Business &…Nov 7, 2025

25,000 sh

CCONV—

Moss Gregory S. · Chief Business &…Nov 7, 2025

3,175 sh

CCONV◆—

Pena Luis C. · President & CEONov 7, 2025

206,355 sh

CCONV—

Pena Luis C. · President & CEONov 7, 2025

24,225 sh · +3.7% own

CCONV◆—

Hopfner Robert Lorne · Director, 10%…Nov 7, 2025

2.5M sh

CCONV◆—

Hopfner Robert Lorne · Director, 10%…Nov 7, 2025

313,571 sh

CCONV◆—

Hopfner Robert Lorne · Director, 10%…Nov 7, 2025

313,571 sh

CCONV◆—

Hopfner Robert Lorne · Director, 10%…Nov 7, 2025

2.1M sh

CCONV◆—

Hopfner Robert Lorne · Director, 10%…Nov 7, 2025

1.9M sh

CCONV◆—

Hopfner Robert Lorne · Director, 10%…Nov 7, 2025

7.2M sh

CCONV◆—

Hopfner Robert Lorne · Director, 10%…Nov 7, 2025

2.6M sh

CCONV◆—

Hopfner Robert Lorne · Director, 10%…Nov 7, 2025

3.6M sh

CCONV◆—

Hopfner Robert Lorne · Director, 10%…Nov 7, 2025

7.1M sh

CCONV◆—

Hopfner Robert Lorne · Director, 10%…Nov 7, 2025

25,790 sh

CCONV—

Hopfner Robert Lorne · Director, 10%…Nov 7, 2025

294,502 sh

CCONV—

Hopfner Robert Lorne · Director, 10%…Nov 7, 2025

1.6M sh

CCONV—

Hopfner Robert Lorne · Director, 10%…Nov 7, 2025

1.4M sh

CCONV—

Hopfner Robert Lorne · Director, 10%…Nov 7, 2025

3,026 sh

CCONV◆—

Ra Capital Management,… · Director, 10%…Nov 7, 2025

5.9M sh

CCONV◆—

Ra Capital Management,… · Director, 10%…Nov 7, 2025

12.9M sh

PBUY$1.5M

Ra Capital Management,… · Director, 10%…Nov 7, 2025

92,904 sh @ $16.00 · +13.4% own

PBUY$18.5M

Ra Capital Management,… · Director, 10%…Nov 7, 2025

1.2M sh @ $16.00 · +76.3% own

CCONV—

Ra Capital Management,… · Director, 10%…Nov 7, 2025

691,441 sh

CCONV—

Ra Capital Management,… · Director, 10%…Nov 7, 2025

1.5M sh

CCONV◆—

Pivotal bioVenture… · Director, 10%…Nov 7, 2025

2.5M sh

CCONV◆—

Pivotal bioVenture… · Director, 10%…Nov 7, 2025

313,571 sh

CCONV◆—

Pivotal bioVenture… · Director, 10%…Nov 7, 2025

313,571 sh

CCONV◆—

Pivotal bioVenture… · Director, 10%…Nov 7, 2025

2.1M sh

CCONV◆—

Pivotal bioVenture… · Director, 10%…Nov 7, 2025

1.9M sh

CCONV◆—

Pivotal bioVenture… · Director, 10%…Nov 7, 2025

7.2M sh

CCONV◆—

Pivotal bioVenture… · Director, 10%…Nov 7, 2025

2.6M sh

CCONV◆—

Pivotal bioVenture… · Director, 10%…Nov 7, 2025

3.6M sh

CCONV◆—

Pivotal bioVenture… · Director, 10%…Nov 7, 2025

7.1M sh

CCONV—

Pivotal bioVenture… · Director, 10%…Nov 7, 2025

294,502 sh

CCONV—

Pivotal bioVenture… · Director, 10%…Nov 7, 2025

1.6M sh

CCONV—

Pivotal bioVenture… · Director, 10%…Nov 7, 2025

1.4M sh

CCONV◆—

Drew Janice Suzann · EVP, OperationsNov 7, 2025

12,500 sh

CCONV—

Drew Janice Suzann · EVP, OperationsNov 7, 2025

1,587 sh · +2.2% own

CCONV◆—

Cohen David E · DirectorNov 7, 2025

51,588 sh

CCONV—

Cohen David E · DirectorNov 7, 2025

6,056 sh · +34.4% own

CCONV◆—

Carver Kyle · Chief Financial…Nov 7, 2025

25,000 sh

CCONV—

Carver Kyle · Chief Financial…Nov 7, 2025

3,175 sh · +4.4% own

CCONV◆—

Bauer Eugene · Chief Medical…Nov 7, 2025

12,500 sh

CCONV◆—

Bauer Eugene · Chief Medical…Nov 7, 2025

206,355 sh

CCONV—

Bauer Eugene · Chief Medical…Nov 7, 2025

25,812 sh · +10.5% own

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

1 of 48 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 6 business days late.

Form 4 filings made after the two-business-day deadline, with the transaction date, the filing date and the number of business days between them.
Traded	Filed	Insider	Past deadline	Largest line	Source
Dec 8, 2025	Dec 18, 2025	Bauer EugeneChief Medical Officer	6days	—	Filing ↗

Bauer EugeneChief Medical Officer

6days

Traded Dec 8, 2025 · filed Dec 18, 2025Filing ↗

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →